Tarsus Pharmaceuticals Inc (TARS) currently has a stock price of $17.50. The stock saw a sharp increase in the last trading session, hitting a high of $18.75 after opening at $18.44. The lowest recorded price for the day was $17.49 before it closed at $18.86.
The market performance of Tarsus Pharmaceuticals Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $25.25 on 07/24/23, with the lowest value for the same timeframe being $11.33, recorded on 04/17/23.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
52-week price history of TARS Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Tarsus Pharmaceuticals Inc’s current trading price is -30.69% away from its 52-week high, while its distance from the 52-week low is 54.46%. The stock’s price range during this period has fluctuated between $11.33 and $25.25. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.57 million for the day, which was evidently higher than the average daily volume of 0.47 million over the last three months.
Financial Performance and Market Capitalization
Tarsus Pharmaceuticals Inc (TARS) has experienced a quarterly rise of 1.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 579.25M and boasts a workforce of 87 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.95, with a change in price of -0.28. Similarly, Tarsus Pharmaceuticals Inc recorded 495,833 in trading volume during the last 100 days, posting a change of -1.57%.
TARS Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TARS stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.14.
TARS Stock Stochastic Average
Tarsus Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 72.82%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 71.56%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 79.80% and 81.44%, respectively.
TARS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 19.37%.However, over the last six months, we can see a weaker performance of 7.76%. Over the last 30 days, the price of TARS has fallen by 33.49%. And in the last five days, it has surged by 1.92%.
